Varaico: Literature-Extracted Genetic Variants

Gene:AGXT
Variant:p.G47R
Back to variants list

AGXT

NM_000030.3:p.G47R

Associated Papers

A scalable approach to resolving variants of uncertain significance.

Tejura M et al.

Biorxiv : the Preprint Server for Biology, 2026

41727046 (PubMed )
Supplement: media-7.xlsx › VarChAMP_data_supp_mat_PP

Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression.

Kader T et al.

The Journal of Pathology, 2026

41165701 (PubMed )
Supplement: PATH-268-1-s001.zip › path6461-sup-0001-SuppMatMethFiguresS1-S18TablesS1-S9 › path6461-sup-0003-TableS4.xlsx › Variants_recurrence_cases

Global genetic prevalence estimates of primary hyperoxaluria are greater than previously reported.

Mandrile G et al.

Clinical Kidney Journal, 2025

40873808 (PubMed )
Supplement: sfaf194_Supplemental_File.docx

Effect of the allelic background on the phenotype of primary hyperoxaluria type I.

Mandrile G et al.

Current Opinion in Nephrology and Hypertension, 2025

A molecular journey on the pathogenesis of primary hyperoxaluria.

Cellini B

Current Opinion in Nephrology and Hypertension, 2024

Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium.

Metry EL et al.

Kidney International Reports, 2023

Genetic assessment in primary hyperoxaluria: why it matters.

Mandrile G et al.

Pediatric Nephrology (berlin, Germany), 2023

Molecular analysis of the AGXT gene in Syrian patients suspected with primary hyperoxaluria type 1.

Murad H et al.

Bmc Medical Genomics, 2021

A novel nonsense variant of the AGXT identified in a Chinese family: special variant research in the Chinese reference genome.

Xu CB et al.

Bmc Nephrology, 2021

33691640 (PubMed )
Supplement: 12882_2021_2276_MOESM5_ESM.xlsx › Sheet1

Clinical experience with carrier screening in a general population: support for a comprehensive pan-ethnic approach.

Westemeyer M et al.

Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2020

32366966 (PubMed )
Supplement: 41436_2020_807_MOESM1_ESM.docx

Pyridoxine Responsiveness in a Type 1 Primary Hyperoxaluria Patient With a Rare (Atypical) AGXT Gene Mutation.

Singh P et al.

Kidney International Reports, 2020

32518881 (PubMed )
Supplement: mmc1.docx

Folding Defects Leading to Primary Hyperoxaluria.

Oppici E et al.

Handbook of Experimental Pharmacology, 2018

Effects of interface mutations on the dimerization of alanine glyoxylate aminotransferase and implications in the mistargeting of the pathogenic variants F152I and I244T.

Dindo M et al.

Biochimie, 2016

Two novel AGXT mutations identified in primary hyperoxaluria type-1 and distinct morphological and structural difference in kidney stones.

Wang C et al.

Scientific Reports, 2016

Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine.

Montioli R et al.

Biochimica Et Biophysica Acta, 2015

Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type.

Mandrile G et al.

Kidney International, 2014

Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis.

Monico CG et al.

Journal of the American Society of Nephrology : Jasn, 2007

Modeling the effect of 3 missense AGXT mutations on dimerization of the AGT enzyme in primary hyperoxaluria type 1.

Robbiano A et al.

Journal of Nephrology, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."